WNN1062-D002 | m-entrepreneurship.com

Product Name :
WNN1062-D002

Search keywords :
SUMO Conjugating Enzyme UBC9

drugId :
null

Target Vo:
SUMO-conjugating enzyme UBC9

Target Vo Short Name :
UBE2I

Moa_Name:
SUMO-conjugating enzyme UBC9 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:

Termination Status :
Preclinical

China Termination Status :

Highest Status:
Discontinued

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
ATP citrate lyase Antibody
iNOS Antibody
MCM2 Antibody: MCM2 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 102 kDa, targeting to MCM2. It can be used for WB,IHC-P,ICC,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts